BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  TG Therapeutics, Inc. Announces Preclinical & Clinical Data Presentations at the 59th American Society of Hematology Annual Meeting

  Clinical presentations continue to underscore safety profile of TGR-1202 as monotherapy and in combination, including in long-term follow-up.

  December 11, 2017

   · 

  9 min read
• ALK: Registration of Capital Increase of DKK 92,076 AA Shares and DKK 920,760 B Shares By the Issue of New Shares Completed

  This release does not contain or constitute an offer of, or the solicitation of an offer to buy or subscribe for, securities to any person in the United States, Australia, Canada or Japan.

  December 11, 2017

   · 

  1 min read
• Drug Development

  Agios Presents Updated Data from DRIVE PK Study Demonstrating AG-348 is Well-Tolerated and Results in Clinically Relevant, Rapid and Sustained Hemoglobin Increases in Patients with Pyruvate Kinase Deficiency

  DRIVE PK is an ongoing global open-label, Phase 2, safety and efficacy trial evaluating AG-348 in 52 adult, transfusion-independent patients with PK deficiency.

  December 11, 2017

   · 

  8 min read
• Drug Development

  Primary Analysis Results From Novartis Pivotal JULIET Trial Show Kymriah(TM) (Tisagenlecleucel) Sustained Complete Responses at Six Months in Adults With R/R DLBCL, a Difficult-to-Treat Cancer

  The median duration of response was not reached.

  December 11, 2017

   · 

  17 min read
• Bio NC

  Rho Named Triangle Business Journal 2017 Family Business Award Winner

  The award recognizes multigenerational, family-owned, as well as closely held businesses in the Triangle for overall excellence, innovation, ethics, philanthropy and contribution to the strength of the region.

  December 11, 2017

   · 

  1 min read
• Myriad Genetics Presents Results From Two Important EndoPredict Studies to the 2017 San Antonio Breast Cancer Symposium

  EndoPredict is a second-generation prognostic gene expression test for patients with breast cancer.

  December 11, 2017

   · 

  10 min read
• 

  FDA

  FDA Approves Sanofi’s Admelog, the First Follow-On Insulin to Control Sugar at Mealtime

  Admelog is a rapid-acting insulin similar to Humalog, another insulin lispro 100 Units/mL, currently approved in the U.S.

  December 11, 2017

   · 

  6 min read
• Drug Development

  uniQure Announces Updated, Long-Term Clinical Data From Ongoing Phase I/II Trial of AMT-060 in Patients With Severe Hemophilia B

  The data includes up to two years of follow-up from the low-dose cohort and up to 18 months of follow-up from the second, higher-dose cohort.

  December 11, 2017

   · 

  7 min read
• Business

  Valerijs Maligins, Chairman of the Board of AS Olainfarm Has Passed Away

  Valerijs Maligins became Chairman of Olainfarm’s Board after the privatization of the company in 1997.

  December 11, 2017

   · 

  1 min read
• Policy

  Oasmia Pharma Receives Marketing Approval for Paclical in Kazakhstan

  Paclical will be sold through Hetero Group and is planned to be launched during the first half of 2018.

  December 11, 2017

   · 

  1 min read